In this Michigan Medicine Health Lab article, hematologist Matthew Pianko, M.D., from the University of Michigan Health Rogel Cancer Center discusses groundbreaking advances in multiple myeloma treatment. He highlights new immune-targeting drugs, CAR T-cell therapy, genetic insights, and expanded access to clinical trials. With survival rates improving significantly, these innovations offer hope for better, more personalized care.
